Discover
FOLD
Amicus Therapeutics Inc
14.49
22 x 14.48
29 x 14.50
bid
ask
+
0.00
0.00%
26 @ 04:00 PM
14.49 +0.00 (0.00%)
| Ytd | 1.76% | |
| 1y | 97.14% |
14.49
day range
14.50
5.51
52 week range
14.50
| Open | 14.49 | Prev Close | 14.49 | Low | 14.49 | High | 14.50 | Mkt Cap | 4.55B |
| Vol | 5.29M | Avg Vol | 3.92M | EPS | -0.09 | P/E | N/A | Forward P/E | 15.09 |
| Beta | 0.48 | Short Ratio | 6.36 | Inst. Own | 104.39% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 14.40 | 200-d Avg | 10.88 | 1yr Est | 14.50 |
| Income Statement | |||
| Total Revenue | 185.21M | ||
| Revenues (USD) | 185.21M | ||
| Cost of Revenue | 26.55M | ||
| Gross Profit | 158.67M | ||
| Operating Expenses | 142.72M | ||
| Research and Development Expense | 23.74M | ||
| Selling, General and Administrative Expense | 117.08M | ||
| Operating Income | 15.95M | ||
| Interest Expense | 11.43M | ||
| Income Tax Expense | 1.45M | ||
| Net Income | 1.69M | ||
| Net Income Common Stock | 1.69M | ||
| Net Income Common Stock (USD) | 1.69M | ||
| Consolidated Income | 1.69M | ||
| Earning Before Interest & Taxes (EBIT) | 14.57M | ||
| Earning Before Interest & Taxes (USD) | 14.57M | ||
| Weighted Average Shares | 309.04M | ||
| Weighted Average Shares Diluted | 309.04M | ||
| Balance Sheet | |||
| Cash and Equivalents | 214.01M | ||
| Cash and Equivalents (USD) | 214.01M | ||
| Investments | 79.53M | ||
| Investments Current | 79.53M | ||
| Trade and Non-Trade Receivables | 115.31M | ||
| Current Assets | 676.17M | ||
| Property, Plant & Equipment Net | 48.25M | ||
| Total Assets | 949.87M | ||
| Debt Current | 8.74M | ||
| Total Debt | 442.36M | ||
| Current Liabilities | 237.83M | ||
| Debt Non-Current | 433.62M | ||
| Total Liabilities | 675.63M | ||
| Accumulated Retained Earnings (Deficit) | -2.77B | ||
| Accumulated Other Comprehensive Income | 24.11M | ||
| Shareholders Equity | 274.24M | ||
| Shareholders Equity (USD) | 274.24M | ||
| Assets Non-Current | 273.70M | ||
| Total Debt (USD) | 442.36M | ||
| Goodwill and Intangible Assets | 211.71M | ||
| Inventory | 228.82M | ||
| Liabilities Non-Current | 437.80M | ||
| Trade and Non-Trade Payables | 28.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.90M | ||
| Net Cash Flow from Financing | 14.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.46M | ||
| Capital Expenditure | -299.00K | ||
| Issuance (Purchase) of Equity Shares | 18.72M | ||
| Issuance (Repayment) of Debt Securities | -232.00K | ||
| Net Cash Flow from Investing | -6.49M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -6.19M | ||
| Net Cash Flow from Operations | 16.25M | ||
| Effect of Exchange Rate Changes on Cash | -329.00K | ||
| Share Based Compensation | 26.59M | ||